Cell Therapy Market
Cell Therapy Market - Global Industry Assessment & Forecast
#
Pages:
187
Base Year:
2022
Jan - 2022
Format:
Report Code:
VMR-1236
Segments Covered
By
Use-Type Clinical Use, Research Use
-
By
Type Autologous Therapies, Allogenic Therapies
-
By
Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 11.21 Billion |
 Revenue 2030:
|
USD 27.95 Billion |
 Revenue CAGR
(2023 - 2030): |
12.10% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Cell Therapy Market Segment Analysis
- Cell Therapy Use-Type Outlook (Revenue, USD Million, 2018 - 2030)
- Clinical Use
- Research Use
- Cell Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Autologous Therapies
- Allogenic Therapies
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
-
North America Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- U.S.
- U.S. Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- U.S. Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- U.S. Cell Therapy Market, by Use-Type
- Canada
- Canada Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Canada Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Canada Cell Therapy Market, by Use-Type
-
Mexico
- Mexico Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Mexico Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Mexico Cell Therapy Market, by Use-Type
-
North America Cell Therapy Market, by Use-Type
- Europe
-
Europe Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
-
Europe Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- U. K.
- U.K. Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- U.K. Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- U.K. Cell Therapy Market, by Use-Type
- France
- France Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- France Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- France Cell Therapy Market, by Use-Type
-
Germany
- Germany Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Germany Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Germany Cell Therapy Market, by Use-Type
-
Italy
- Italy Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Italy Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Italy Cell Therapy Market, by Use-Type
-
Spain
- Spain Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Spain Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Spain Cell Therapy Market, by Use-Type
-
Rest of Europe
- Rest of Europe Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Rest of Europe Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Rest of Europe Cell Therapy Market, by Use-Type
-
Europe Cell Therapy Market, by Use-Type
- Asia Pacific
-
Asia Pacific Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
-
Asia Pacific Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- China
- China Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- China Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- China Cell Therapy Market, by Use-Type
- Japan
- Japan Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Japan Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Japan Cell Therapy Market, by Use-Type
-
Germany
- Germany Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Germany Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Germany Cell Therapy Market, by Use-Type
-
India
- India Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- India Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- India Cell Therapy Market, by Use-Type
-
South Korea
- South Korea Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- South Korea Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- South Korea Cell Therapy Market, by Use-Type
-
South East Asia
- South East Asia Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- South East Asia Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- South East Asia Cell Therapy Market, by Use-Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Rest of Asia Pacific Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Rest of Asia Pacific Cell Therapy Market, by Use-Type
-
Asia Pacific Cell Therapy Market, by Use-Type
- Latin America
-
Latin America Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
-
Latin America Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Brazil
- Brazil Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Brazil Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Brazil Cell Therapy Market, by Use-Type
- Argentina
- Argentina Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Argentina Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Argentina Cell Therapy Market, by Use-Type
-
Rest of Latin America
- Rest of Latin America Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Rest of Latin America Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Rest of Latin America Cell Therapy Market, by Use-Type
-
Latin America Cell Therapy Market, by Use-Type
- Middle East & Africa
-
Middle East & Africa Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
-
Middle East & Africa Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- GCC Countries
- GCC Countries Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- GCC Countries Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- GCC Countries Cell Therapy Market, by Use-Type
- South Africa
- South Africa Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- South Africa Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- South Africa Cell Therapy Market, by Use-Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Cell Therapy Market, by Use-Type
- Clinical Use
- Research Use
- Rest of Middle East & Africa Cell Therapy Market, by Type
- Autologous Therapies
- Allogenic Therapies
- Rest of Middle East & Africa Cell Therapy Market, by Use-Type
-
Middle East & Africa Cell Therapy Market, by Use-Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Cell Therapy in terms of revenue?
-
The global Cell Therapy valued at USD 11.21 Billion in 2022 and is expected to reach USD 27.95 Billion in 2030 growing at a CAGR of 12.10%.
Which are the prominent players in the market?
-
The prominent players in the market are The major companies of the studied market are Pharmicell Co. Ltd, Corestem Inc., Chiesi Farmaceutici SpA, Tegoscience, Anterogen Co. Ltd, TiGenix (Takeda Pharmaceuticals), Stempeutics Research Pvt Ltd, Nipro Corporation, and Medipost Co. Ltd..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 12.10% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cell Therapy include
- Rising Government Investments in Cell-Based Research
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cell Therapy in 2022.
